🟢 20/20 Biolabs is trading 5.56% up today as XBI gains 2.75%

20/20 Biolabs is trading at $0.65 with a +5.56% gain, primarily amid biotech-sector strength.

• Biotech stocks provided a supportive backdrop, with XBI up 2.75% during regular trading.
• No confirmed company-specific catalyst has been identified for the September 2 move.
• Investor attention may be elevated ahead of the September 2 webinar, rescheduled to 2:00 p.m. Eastern, where management will discuss record OneTest revenue and commercial expansion.